CMS To Use Procedure Codes To Track Remdesivir, Plasma Use

By Michelle M. Stein / July 30, 2020 at 4:01 PM
CMS plans to put in place new hospital procedure codes starting Aug. 1 that will allow the agency and other insurers to track the use and effectiveness of COVID-19 treatments in real-time. “CMS is implementing new procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19,” CMS notified Capitol Hill on Thursday (July 30). “These new codes, which go into effect August 1, will enable...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.